Gene therapy of transplant arteriopathy by liposome-mediated transfection of endothelial nitric oxide synthase

Journal of Heart and Lung Transplantation

Volumn 19, Issue 11, 2000, Pages 1017-1028

  Iwata, Akiko ^a,f   Sai, Sadahiro ^b   Moore, Mark ^a   Nyhuis, John ^a   De Fries Hallstrand, Ricarda ^c   Quetingco, Grace C ^d   Allen, Margaret D ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b TOHOKU UNIVERSITY   (Japan)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Urigen Pharmaceuticals Inc   (United States)

^e Hope Heart Research Institute   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CHLORAMPHENICOL ACETYLTRANSFERASE; DNA; GENE PRODUCT; INTERCELLULAR ADHESION MOLECULE 1; LIPOSOME; NITRIC OXIDE SYNTHASE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DISEASE; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; REPORTER GENE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CAROTID ARTERIES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENE THERAPY; HEART TRANSPLANTATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIPOSOMES; MACROPHAGES; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE SYNTHASE; RABBITS; T-LYMPHOCYTES; TRANSFECTION; TUNICA INTIMA; TUNICA MEDIA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033758775     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00200-X     Document Type: Article

References (40)

1. Nitric oxide synthase: Role in the genesis of vascular disease
2. Transfer and expression of recombinant nitric oxide synthase genes in the cardiovascular system
3. Inducible nitric oxide synthase and vascular injury
4. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene
5. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis
6. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats
7. Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium
8. Improvement of relaxation in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase
9. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs
10. Optimization of ex vivo inducible nitric oxide synthase gene transfer to vein grafts
11. Intraoperative liposome-mediated gene transfection of nitric oxide synthase (ecNOS) reduces ischemia-reperfusion injury in transplanted hearts
12. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis
13. Vascular smooth muscle cells express VCAM-1 and embryonic myosin isoforms in transplant arteriopathy
14. Gene therapy for donor hearts: Ex vivo liposome-mediated transfection
15. Characterization and in vivo testing of a heterogeneous cationic lipid-DNA formulation
16. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice
17. In vivo studies of gene expression via transient transgenesis using lipid-DNA delivery
18. Antibody to CD18 reduces neutrophil and T-lymphocyte infiltration and VCAM-1 expression in cardiac rejection
19. Transfection of rabbit arteries results in gene expression and development of a non-inflammatory neointimal lesion
20. Expression patterns of MHC class II genes in rabbit tissues indicate close homology to human counterparts
21. Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide
22. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha
23. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
24. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis
25. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis
26. Antibody to VLA-4 reduces medial smooth muscle cell proliferation and VCAM-1 expression in post transplant arteriopathy
27. Vascular cell adhesion molecule-1 gene expression during human smooth muscle cell differentiation is independent of NFκB activation
28. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity
29. NO alters cell shape and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B activation
30. Expression and function of recombinant endothelial NO synthase in coronary artery smooth muscle cells
31. NOS gene transfer inhibits expression of cell cycle regulatory molecules in vascular smooth muscle cells
32. Enhanced recovery of injury-caused downregulation of paxillin protein by eNOS gene expression in rat carotid artery. Mechanism of NO inhibition of intimal hyperplasia?
33. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype
34. Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy
35. Myosin isoform expression and smooth muscle cell heterogeneity in normal and atherosclerotic rabbit aorta
36. Correlation between the presence of an immature smooth muscle cell population in tunica media and the development of atherosclerotic lesions: A study on different-sized rabbit arteries from cholesterol-fed and Watanabe heritable hyperlipemic rabbits
37. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma
38. Inhibition of intimal hyperplasia after vein grafting by in vivo transfer of human senescent cell-derived inhibitor-1 gene
39. NO inhibits cytokine-induced iNOS expression and NF-kappa B activation by interfering with phosphorylation and degradation of Ikappa B-alpha
40. Superoxide and peroxynitrite in atherosclerosis